Therapeutic Approaches That Achieve the Best Possible Outcomes in Myeloma Care

In this online program experts discuss current best practices to enhance patient care across the spectrum of multiple myeloma. Read expert commentaries on the most recent clinical data to learn more about how to select optimal therapy for your patients with myeloma.

Share

Program Content

Activities

MM Challenges
My Thoughts on Today’s Biggest Challenges in Myeloma Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2019

Expires: October 20, 2020

MRD Status in MM
MRD Status: A New Era of Individualized Medicine in Multiple Myeloma Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

FAQ in Multiple Myeloma
Frequently Asked Questions in Multiple Myeloma Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2020

Expires: March 01, 2021

Faculty

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

cover img faculity

Jesús F. San-Miguel, MD, PhD

Head, Hematology Department
Professor of Medicine
Hospital Universitario de Salamanca and Centro de Investigación del Cáncer
University of Salamanca
Salamanca, Spain

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Celgene

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Oncopeptides

Takeda Oncology

The Binding Site

Partners

IMF 2018

ProCE Banner